Evidence map›Paper›PMID 25972574›Full record

Trial reportDiabetes care2015

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD.

L Maria Belalcazar, Wei Lang, Steven M Haffner, Dawn C Schwenke, Andrea Kriska, Ashok Balasubramanyam, Ron C Hoogeveen, F Xavier Pi-Sunyer, Russell P Tracy, Christie M Ballantyne and 1 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH.Liver international : official journal of the International Association for the Study of the Liver · 2021
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

L Maria BelalcazarDepartment of Medicine, University of Texas Medical Branch at Galveston, Galveston, TX lmbelalc@utmb.edu.
Wei LangDepartment of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC.
Steven M HaffnerDepartment of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX.
Dawn C SchwenkeCollege of Nursing & Health Innovation, Arizona State University, Phoenix, AZ.
Andrea KriskaDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, PA.
Ashok BalasubramanyamDepartment of Medicine, Baylor College of Medicine, Houston, TX.
Ron C HoogeveenDepartment of Medicine, Baylor College of Medicine, Houston, TX.
F Xavier Pi-SunyerDepartment of Medicine, Columbia University, St. Luke's-Roosevelt Hospital, New York, NY.
Russell P TracyDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT.
Christie M BallantyneDepartment of Medicine, Baylor College of Medicine, Houston, TX Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart & Vascular Center, Houston, TX.
Look AHEAD (Action for Health in Diabetes) Research Group

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
RESEARCH TRAININGP30DK026687 · NIDDK · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI Anthony W Ferrante, DYMPNA GALLAGHER · 1986 to 2026
$33.0M
UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
Obesity, Inflammation and Thrombosis: LOOK AHEADR01HL090514 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI BALLANTYNE, CHRISTIE MITCHELL · 2007 to 2010
$2.7M
NCRR NIH HHS UL1 RR025758NHLBI NIH HHS HL-090514-01NHLBI NIH HHS R01 HL090514NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK026687NIDDK NIH HHS P30 DK098722
6 · The paper itself

Abstract

objectiveThis study investigated whether fitness changes resulting from lifestyle interventions for weight loss may independently contribute to the improvement of low adiponectin levels in obese individuals with diabetes. RESEARCH DESIGN AND

methodsLook AHEAD (Action for Health in Diabetes) randomized overweight/obese individuals with type 2 diabetes to intensive lifestyle intervention (ILI) for weight loss or to diabetes support and education (DSE). Total and high-molecular weight adiponectin (adiponectins), weight, and cardiorespiratory fitness (submaximal exercise stress test) were measured in 1,397 participants at baseline and at 1 year, when ILI was most intense. Regression analyses examined the associations of 1-year weight and fitness changes with change in adiponectins.

resultsILI resulted in greater improvements in weight, fitness, and adiponectins at 1 year compared with DSE (P < 0.0001). Weight loss and improved fitness were each associated with changes in adiponectins in men and women (P < 0.001 for all), after adjusting for baseline adiponectins, demographics, clinical variables, and treatment arm. Weight loss contributed an additional 4-5% to the variance of change in adiponectins than did increased fitness in men; in women, the contributions of improved fitness (1% greater) and of weight loss were similar. When weight and fitness changes were both accounted for, weight loss in men and increased fitness in women retained their strong associations (P < 0.0001) with adiponectin change.

conclusionsImprovements in fitness and weight with ILI were favorably but distinctly associated with changes in adiponectin levels in overweight/obese men and women with diabetes. Future studies need to investigate whether sex-specific biological determinants contribute to the observed associations.

Indexed as

Risk Reduction BehaviorAdiponectinAdultDiabetes Mellitus, Type 2Diabetic AngiopathiesExercise TestExercise TherapyFemaleHumansLife StyleMaleMiddle AgedObesityOverweightPhysical FitnessWeight LossAdiponectinADIPOQ protein, human

Identifiers

PMID25972574
PMCPMC4512135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.